Application and study of acupoint catgut embedding combined with indacaterol/glycopyrrolate on chronic obstructive pulmonary disease of lung-kidney qi deficiency type
Objective To explore the application effect of acupoint thread embedding combined with indaterol/glucuronium bromide on chronic obstructive pulmonary disease(COPD)of lung kidney qi deficiency type.Methods A total of 60 patients with COPD of lung and kidney qi deficiency type admitted to the Respiratory and Critical Care Medicine Department of the First Affiliated Hospital of Guangxi University of Science and Technology from July 2022 to January 2023 were selected for this clinical practice study.They were randomly divided into two groups using a random number table method,with 30 patients in the control group and 30 patients in the observation group.The control group was treated with indatelopram/glucuronium bromide,while the observation group was treated with acupoint catgut embedding combined with indatelopram/glucuronium bromide.The treatment effects of the two groups were compared.Results Before treatment,there was no statistically significant difference in the levels of forced vital capacity(FVC)and forced expiratory volume in one second(FEV1)between the two groups of lung function indicators(P＞0.05).After treatment,the lung function indicators FVC and FEV1 levels in the observation group were higher than those in the control group,with the differences were statistically significant(P＜0.05).The total incidence of adverse reactions in the observation group was lower than that in the control group,with the differences were statistically significant(P＜0.05).The total effective rate of treatment was higher in the observation group than in the control group,with the differences were statistically significant(P＜0.05).Conclusion The combination of acupoint catgut embedding and indaterol/glucuronium bromide has a significant therapeutic effect on COPD of lung kidney qi deficiency type.
Acupoint catgut embeddingIndacaterol/glycopyrrolateChronic obstructive pulmonary disease of lung-kidney qi deficiency typePulmonary function
万方数据
维普
